AXL and MET Receptor Tyrosine Kinases Are Essential for Lung Cancer Metastasis

Oncology Reports - Greece
doi 10.3892/or.2017.5482
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Computational Design of Druglike Allosteric Inhibitors of AXL and MET Receptor Tyrosine Kinases

Biophysical Journal
Biophysics
2019English

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2004English

AXL Receptor Tyrosine Kinase (AXL; UFO)

Science-Business eXchange
2014English

Cross-Talk Between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells

Cancer Research
Cancer ResearchOncology
2019English

Exploring Receptor Tyrosine Kinases-Inhibitors in Cancer Treatments

Egyptian Journal of Medical Human Genetics
Genetics
2019English

Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases

Breast Cancer Research
Cancer ResearchOncology
2000English

Interplay Between Receptor Tyrosine Kinases and Hypoxia Signaling in Cancer

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2015English

Signaling by Receptor Tyrosine Kinases

Annual Review of Biochemistry
Biochemistry
1993English

Identification of Metabolic Vulnerabilities of Receptor Tyrosine Kinases-Driven Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy